These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2149548

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
    Aushri Z, Berginer V, Nathan I, Dvilansky A.
    Int J Clin Pharmacol Res; 1983; 3(5):339-42. PubMed ID: 6206005
    [Abstract] [Full Text] [Related]

  • 24. Platelet activation indices and apolipoproteins in hypertensive patients.
    Catalano M, Belletti S, Russo U, Aronica A, Carzaniga G, Seregni R, Libretti A.
    J Hum Hypertens; 1988 Oct; 2(3):195-7. PubMed ID: 2976836
    [Abstract] [Full Text] [Related]

  • 25. Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women.
    Mundal HH, Nordby G, Lande K, Gjesdal K, Kjeldsen SE, Os I.
    Scand J Clin Lab Invest; 1993 Oct; 53(6):585-91. PubMed ID: 8266004
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension.
    Islim IF, Beevers DG, Bareford D.
    J Hypertens; 1992 Apr; 10(4):379-83. PubMed ID: 1349904
    [Abstract] [Full Text] [Related]

  • 30. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
    Bühler FR, Amstein R.
    Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients.
    Mores N, Martire M, Pistritto G, Volpe AR, Menini E, Folli G, Cardillo C.
    J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
    Al-Mondhiry H, Pierce WS, Pennock JL.
    J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis.
    Kuhlmann U, Steurer J, Rhyner K, von Felten A, Briner J, Siegenthaler W.
    Clin Nephrol; 1981 May; 15(5):229-35. PubMed ID: 6166421
    [Abstract] [Full Text] [Related]

  • 37. Effects of antihypertensive treatment on platelet function in essential hypertension.
    Gomi T, Ikeda T, Shibuya Y, Nagao R.
    Hypertens Res; 2000 Nov; 23(6):567-72. PubMed ID: 11131267
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Pathophysiology of hypertension. e. Essential hypertension and platelet functions].
    Katori R, Kohashi N, Okabayashi T.
    Nihon Rinsho; 1984 Feb; 42(2):352-8. PubMed ID: 6232408
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.